Dow Up 1.16% Nasdaq Up 2.19%

Novavax, Inc. (NVAX)

-NasdaqGS
4.95 Down 0.06(1.13%) 3:39PM EDT - Nasdaq Real Time Price
Prev Close:5.01
Open:5.04
Bid:4.99 x 4300
Ask:5.00 x 15100
1y Target Est:10.07
Beta:1
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.92 - 5.05
52wk Range:2.68 - 6.95
Volume:1,489,521
Avg Vol (3m):3,220,050
Market Cap:1.18B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.13%1.18B
MRKUp 1.91%158.90B
NVSUp 0.71%214.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback